Zhiguo Mao
Overview
Explore the profile of Zhiguo Mao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
459
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xia Y, Ye Z, Li B, Yan X, Yuan T, Li L, et al.
Commun Biol
. 2025 Feb;
8(1):286.
PMID: 39987296
Long-term nephrocalcinosis leads to kidney injury, fibrosis, and even chronic kidney disease (CKD). Macrophage-to-myofibroblast transition (MMT) has been identified as a new mechanism in CKD, however, the effect of MMT...
2.
Mao Z, Lin X, Hu Y, Liu Y, Yu S, Zhou T, et al.
Phytomedicine
. 2025 Feb;
139:156496.
PMID: 39951973
Background: Pulmonary sarcoidosis (PS) is an immune-mediated disorder characterised by a significant association with various immune cell types including macrophages, T-helper 1 (TH1) cells, and TH17 cells. Dysregulation of immune...
3.
Chen Z, Fu S, Wu J, Luo X, Mao Z, Xu D, et al.
Kidney Med
. 2025 Feb;
7(2):100945.
PMID: 39895853
Despite treatment with immunosuppressive or clone-targeted chemotherapy, patients with proliferative glomerulonephritis with monoclonal immunoglobulin deposit (PGNMID) frequently progress into end-stage kidney failure, and early recurrence of PGNMID after kidney transplantation...
4.
Xue C, Lv J, Yang B, Mei S, Xu J, Li X, et al.
J Transl Int Med
. 2025 Jan;
12(6):543-552.
PMID: 39802450
Polycystic kidney disease (PKD) is a genetic disorder marked by numerous cysts in the kidneys, progressively impairing renal function. It is classified into autosomal dominant polycystic kidney disease (ADPKD) and...
5.
Mei S, Xue C, Zhang Z, Liu L, Cai W, Gong X, et al.
J Blood Med
. 2024 Dec;
15:495-500.
PMID: 39633652
Background: Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection has been a global threat since the end of 2019. Although the main clinical manifestation of coronavirus disease 2019 (COVID-19) is respiratory,...
6.
7.
Xue C, Cui L, Chen J, Liu Y, Deng Y, Xu W, et al.
Front Pharmacol
. 2024 Nov;
15:1420377.
PMID: 39605911
Lenvatinib, a multi-target inhibitor of receptor tyrosine kinases, has been increasingly used in the treatment of advanced hepatocellular carcinoma (HCC). However, its association with renal adverse effects, including proteinuria and...
8.
Zhang J, Tian S, Guo L, Zhao H, Mao Z, Miao M
J Transl Med
. 2024 Nov;
22(1):1059.
PMID: 39587576
Extracellular vesicles (EVs) are phospholipid bilayer-enclosed biological particles that are secreted by almost all living cells including animals, plants, and microorganisms. Chinese herbal medicines (CHM) have a long history of...
9.
Yang Y, Kong D, Chen M, Lv J, Zhou J, Xue C, et al.
Nephrol Dial Transplant
. 2024 Nov;
PMID: 39528237
Background And Hypothesis: The levels of C5b-9, terminal products of complement activation, were significantly elevated in autosomal dominant polycystic kidney disease (ADPKD). However, the precise mechanisms by which C5b-9 facilitates...
10.
Lv J, Lan B, Fu L, He C, Zhou W, Wang X, et al.
J Transl Med
. 2024 Oct;
22(1):979.
PMID: 39472935
Background: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a prevalent genetic disorder characterized by the formation of renal cysts leading to kidney failure. Despite known genetic underpinnings, the variability in...